Virax Biolabs Group Ltd (VRAX) Operating income 2021–2025
Virax Biolabs Group Ltd (VRAX) annual operating income history from SEC filings — each fiscal year as reported.
-$6.2MFY2025 · since FY2021: -$644,538 → -$6.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$6.2M | +5.1% |
| FY2024 | -$6.5M | -13.3% |
| FY2023 | -$5.7M | -230.7% |
| FY2022 | -$1.7M | -169.0% |
| FY2021 | -$644,538 | — |
Source: SEC XBRL filings · For reference only · Not investment advice